Ab­b­Vie pours $223M in­to build­ing out its bi­o­log­ics ca­pac­i­ty in Sin­ga­pore

Ab­b­Vie is not on­ly build­ing out its pipeline, but al­so its man­u­fac­tur­ing foot­print. The Chica­go-based phar­ma is spend­ing $223 mil­lion to ex­tend its on­ly man­u­fac­tur­ing site in Asia and boost its bi­o­log­ics pro­duc­tion.

The fa­cil­i­ty in Sin­ga­pore, which can al­ready pro­duce bi­o­log­ics and small mol­e­cules, is en­vi­sioned to add at least 100 jobs to a to­tal of around 500 work­ers once it’s ful­ly op­er­a­tional. The ex­ten­sion will boost its bi­o­log­ics drug sub­stance ca­pa­bil­i­ties by 24,000 liters.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER